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Regulation of the unfolded protein 
response via S-nitrosylation of 
sensors of endoplasmic reticulum 
stress
Ryosuke Nakato1,*, Yu Ohkubo1,*, Akari Konishi1,*, Mari Shibata1, Yuki Kaneko1, 
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Protein S-nitrosylation modulates important cellular processes, including neurotransmission, 
vasodilation, proliferation, and apoptosis in various cell types. We have previously reported 
that protein disulfide isomerase (PDI) is S-nitrosylated in brains of patients with sporadic 
neurodegenerative diseases. This modification inhibits PDI enzymatic activity and consequently leads 
to the accumulation of unfolded/misfolded proteins in the endoplasmic reticulum (ER) lumen. Here, 
we describe S-nitrosylation of additional ER pathways that affect the unfolded protein response 
(UPR) in cell-based models of Parkinson’s disease (PD). We demonstrate that nitric oxide (NO) 
can S-nitrosylate the ER stress sensors IRE1α and PERK. While S-nitrosylation of IRE1α inhibited 
its ribonuclease activity, S-nitrosylation of PERK activated its kinase activity and downstream 
phosphorylation/inactivation or eIF2α. Site-directed mutagenesis of IRE1α(Cys931) prevented S-
nitrosylation and inhibition of its ribonuclease activity, indicating that Cys931 is the predominant 
site of S-nitrosylation. Importantly, cells overexpressing mutant IRE1α(C931S) were resistant to NO-
induced damage. Our findings show that nitrosative stress leads to dysfunctional ER stress signaling, 
thus contributing to neuronal cell death.
The endoplasmic reticulum (ER) is involved in many essential cellular processes, including calcium 
homeostasis, steroid synthesis, protein folding and maturation, and quality control of newly synthesized 
proteins1,2. Chaperones in the ER facilitate protein folding and prevent accumulation of misfolded pro-
teins. Correct folding of newly synthesized proteins that contain disulfide bonds and/or an N-glycan is 
facilitated by several ER chaperones, including protein disulphide isomerase (PDI), calnexin, and BiP3,4. 
Only correctly-folded proteins are transported from the rough ER to the Golgi complex for export. 
Severe cellular stress, engendered by hypoxia, energy deprivation, or exposure to excessive reactive 
oxygen or nitrogen species (including nitric oxide (NO)), can lead to ER stress. Such stress triggers 
the unfolded protein response (UPR)5–8, which, if terminated within a moderate amount of time, can 
lead to cytoprotection. However, prolonged ER stress upregulates the pro-apoptotic transcription factor 
C/EBP homologous protein (CHOP), leading to apoptotic cell death9,10.
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The UPR is a stress response that prevents accumulation of unfolded proteins in the ER lumen. 
Unfolded proteins in the ER are detected by transmembrane ER stress sensors11,12. The three major ER 
stress-sensing proteins are PKR-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1), and acti-
vating transcription factor 6 (ATF6)13–15. These sensors transmit signals from the ER to the cytoplasm 
or nucleus, and activate the following three pathways: (i) suppression of protein translation to halt the 
production of more unfolded proteins, (ii) induction of genes encoding ER molecular chaperones to 
facilitate protein folding, and (iii) activation of ER-associated degradation (ERAD) to decrease the accu-
mulation of unfolded proteins in the ER16.
NO regulates numerous cell responses associated with proliferation, neurotransmission, synaptic plas-
ticity, or cytotoxicity, in part via protein S-nitrosylation. This redox-mediated chemical modification 
occurs via oxidative reaction between NO and cysteine (Cys) thiol (or more properly thiolate anion) in 
the presence of an electron acceptor; alternatively, the reaction can proceed via transnitrosylation from 
one S-nitrosothiol to another17–19. We previously demonstrated that PDI is a target of NO under neuro-
degenerative conditions. S-Nitrosylation of PDI (forming SNO-PDI) inhibits its enzymatic activity and 
induces ER stress20. Additionally, we found that NO suppresses expression of mRNAs encoding ER stress 
markers. Therefore, we postulated that unidentified SNO-proteins might be involved in the UPR. In the 
present study, we discovered that a number of ER stress-sensing proteins are S-nitrosylated, suggesting a 
novel regulatory mechanism for UPR activation.
Results
NO regulates the IRE1α pathway during the UPR. We examined mRNA expression of specific 
ER stress markers in response to NO. Exposure to S-nitrosoglutathione (GSNO), a physiological NO 
donor, elevated the mRNA expression level of genes encoding BiP, CHOP, and EDEM1, but not HRD1 
(Fig. 1a). Because HRD1 mRNA expression is known to be dependent on XBP1, it is possible that NO 
regulates this branch of the UPR via IRE1α 21. To determine if NO modulates the UPR in this manner, we 
transfected SH-SY5Y neural cells with a vector expressing the fusion gene XBP1-luciferase (Luc) in order 
to monitor IRE1α activity22. Cells transfected with the XBP1–Luc expression vector showed detectable 
luminescence when treated with thapsigargin (Fig. 1b). However, exposure to high concentrations of NO 
did not significantly affect XBP1–Luc reporter activity, consistent with the notion that the IRE1α -XBP1 
branch was regulated by NO. In addition, NO did not induce cytosolic splicing of XBP1 mRNA (Fig. 1c). 
Next, we asked if NO impaired oligomerization or kinase activity of IRE1α . Empirically, we observed 
that exposure to NO did not attenuate oligomerization or phosphorylation of IRE1α (Fig. 1d,e).
Neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and ER stress attenuate the IRE1α path-
way in an NO synthase (NOS)-dependent manner. MPP+, which is known to cause a parkin-
sonian phenotype in rodents, non-human primates and humans, induces NO production and neuronal 
cell death, at least in part via ER stress23. Therefore, we tested whether MPP+ affected UPR signaling. 
We found that MPP+ induced mRNA expression of BiP and CHOP in a concentration-dependent man-
ner; however, neither splicing of XBP1 mRNA nor phosphorylation of IRE1α was detected under these 
conditions (Fig. 2a,b). To determine whether attenuation of XBP1 mRNA splicing was mediated by NO, 
we treated SH-SY5Y cells with the NOS inhibitor 7-nitroindazole (7-NI), and found that splicing was 
significantly ameliorated (Fig. 2c,d). To further test the effects of ER stress and NO on IRE1α –XBP1 sig-
naling, we induced ER stress with thapsigargin in the presence and absence of exogenous NO. Although 
thapsigargin clearly stimulated XBP1 mRNA splicing, pre-incubation with NO completely abrogated this 
response (Fig. 3a,b). These findings are consistent with the notion that the ribonuclease activity of IRE1α 
is regulated by redox state, specifically via reaction with NO.
S-Nitrosylation of IRE1α at Cys931 attenuates its ribonuclease activity. Next, we determined 
if NO could S-nitrosylate the UPR components IRE1α , PERK, or ATF6. By biotin-switch assay, we found 
that NO mediated S-nitrosylation of IRE1α (to form SNO-IRE1) and PERK (forming SNO-PERK), 
but not ATF6 (Fig.  4a). Therefore, we hypothesized that NO may modulate IRE1α endoribonuclease 
activity by S-nitrosylating the enzyme. Along these lines, two cysteine residues, at positions 931 and 
951, are known to reside in the kinase-extension nuclease (KEN) domain of IRE1α 24,25. To determine 
if these residues were the target site(s) of S-nitrosylation, we substituted each cysteine for serine and 
assessed SNO–IRE1α formation by performing biotin-switch assays. After 24 h, the cells were exposed 
to S-nitrosocysteine (SNOC) or control conditions and were monitored for SNO–IRE1α formation. We 
found that the IRE1α (C931S) mutant nearly totally abrogated S-nitrosylation while the C951S mutant 
had a more modest effect (Fig. 4b,c). These results are consistent with the notion that Cys-931 is the pre-
dominant nitrosylation site on IRE1α . To determine if this S-nitrosylation affected endonuclease activity, 
IRE1α –null mouse embryonic fibroblasts (MEFs) were used26. The MEFs were transfected with vectors 
expressing wild-type (WT) HA-tagged IRE1α or Cys mutant. NO-induced inhibition of IRE1α endonu-
clease activity was significantly ameliorated in MEFs expressing the IRE1α (C931S) mutant (Fig. 4d,e). 
To our knowledge, this is the first demonstration that Cys931 is involved in allosteric regulation of IRE1α 
activity.
Next, to test the potential role of S-nitrosylation of IRE1α in cell death, we investigated the effects 
of the Cys mutants on NO-induced cell damage in IRE1α -null MEFs. Transient expression of IRE1α 
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(C931S) significantly restored cell viability compared with mock transfectants (Fig.  4f). Additionally, 
as expected, overexpression of spliced XBP1 mRNA, but not unspliced XBP1 mRNA, attenuated 
NO-induced cell death (Fig. 4f).
NO enhances eIF2α phosphorylation. As shown above, SNOC or GSNO can S-nitrosylate PERK, 
but not ATF6 (Fig. 4a). Therefore, we investigated whether NO influences PERK activity/phosphoryla-
tion in SH-SY5Y neural cells. ER stress is known to result in the oligomerization and autophosphoryl-
ation of PERK, which then phosphorylates and thus inactivates eIF2α , although other kinases can also 
influence eIF2α activity27. Empirically, we found that NO induced a modest but detectable degree of 
phosphorylation of PERK (Fig. 5a). Additionally, NO significantly enhanced phosphorylation of eIF2α in 
a concentration-dependent manner (Fig. 5a). This resulting phosphorylation was transient and reached 
a peak level ~2 h after stimulation (Fig. 5b,c).
Figure 1. NO regulates the IRE1α-XBP1 pathway. (a) NO-stimulates ER stress-related gene expression. 
SH-SY5Y cells were exposed to 100 μm GSNO (NO) or 1 μ M thapsigargin (Tg) for 12 h. RT-PCR was 
performed using specific primers for each mRNA. (b) NO does not activate XBP1 mRNA signaling. SH-
SY5Y cells were transfected with a vector expressing the XBP1–Luc reporter. After 48 h, the transfected 
cells were exposed to various concentrations of NO or 1 μ M Tg, and luciferase assay was performed. 
Values expressed as mean ± s.e.m. (n = 5). (c) ER stress evoked by NO is independent of XBP1 mRNA 
splicing. SH-SY5Y cells were treated with the indicated concentrations of NO for 12 h, and XBP1 mRNA 
splicing was determined by performing RT-PCR. (d,e) NO induces oligomerization and phosphorylation of 
IRE1α . Lysates of SH-SY5Y cells exposed to NO for the indicated period of time were electrophoresed by 
performing native PAGE and then immunoblotted with anti-IRE1α antibody (d). After exposure to varying 
concentrations of NO for 30 min, the level of phosphorylated IRE1α was detected by western blotting (e).
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Discussion
The present study elucidated the effects of NO on major signaling pathways involved in the UPR. 
Previous reports had shown that NO reacts with PDI to form SNO–PDI in the ER lumen of human 
brains obtained from patients with several neurodegenerative diseases characterized by abnormal protein 
accumulation, including Parkinson’s disease (PD)20. Cell-based models of neurodegeneration produced 
by exposure to NO or mitochondrial toxins known to induce Parkinsonism also displayed formation of 
SNO–PDI. S-Nitrosylation of PDI was shown to impair protein folding, thus promoting ER stress and 
the UPR, as observed in PD28–30. Here, we found that NO also reacts with the major ER stress sensors, 
IRE1α and PERK, thus attenuating UPR and contributing to cell death.
Figure 2. NO modulates MPP+-induced attenuation of the IRE1α pathway. (a) MPP+-stimulated ER 
stress-related gene expression. SH-SY5Y cells were incubated in MPP+ for 24 h. RT-PCR was performed 
using specific primers for each mRNA. (b) Cells were exposed to varying concentrations of MPP+ for 
2 h, and western blotting was performed using anti-phospho-IRE1α antibody. (c) Cells were preincubated 
with 200 μ M 7-NI for 6 h and then stimulated with 500 μ M MPP+ for 12 h. Splicing of XBP1 mRNA was 
assessed by RT-PCR. (d) Quantification of XBP1 mRNA splicing is shown in (c). Values are expressed as 
mean ± s.e.m. (n = 4; *P < 0.05 by ANOVA).
Figure 3. Prior exposure to NO inhibits ER stress-induced XBP1 mRNA splicing. (a) NO attenuates Tg-
stimulated XBP1 mRNA splicing. Cells were preincubated with 100 μ M NO for 30 min and then stimulated 
with 10 μ M Tg for 2 h. Splicing of XBP1 mRNA was assessed by performing RT-PCR. (b) Quantification 
of XBP1 mRNA splicing is shown for data in (a). Values are expressed as mean ± s.e.m. (n = 4; P < 0.01 by 
ANOVA).
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Figure 4. S-nitrosylation of ER stress sensor proteins. (a) SH-SY5Y neural cells transduced with vectors 
expressing wild-type IRE1α , PERK, or ATF6 were incubated with physiological NO donors (SNOC or 
GSNO) to determine S-nitrosylation. Control cells were exposed to old SNOC, from which NO had been 
dissipated, or glutathione. S-Nitrosylated proteins were detected by performing biotin-switch assays. (b) Top: 
SH-SY5Y neural cells, transduced with wild-type (WT) or C-to-S HA-tagged IRE1α mutants, were exposed 
to 100 μ M SNOC or control for 1 h. SNO–IRE1α was detected by biotin-switch assay with anti-HA antibody. 
Bottom: Total IRE1α . (c) Quantification of XBP1 mRNA splicing is shown from (b). Values are mean ± s.e.m. 
(n = 4; P < 0.05 or 0.01 by ANOVA). (d) XBP1 mRNA splicing in IRE1α -null MEFs. IRE1α -null MEFs 
transduced with WT or IRE1α C-to-S mutants were exposed to 100 μ M SNOC for 12 h, and XBP1 mRNA 
splicing was assessed by performing RT-PCR. (e) Quantification of XBP1 mRNA splicing. Values are 
mean ± s.e.m. (n = 4; P < 0.05 by ANOVA). (f) Overexpression of IRE1α (C931S) mutant or spliced XBP1 
mRNA prevented NO-induced cell death of IRE1α -null MEFs. Cell viability was estimated by performing 
WST-1 assay (see Methods). Values are mean ± s.e.m. (n = 4; P < 0.05 by ANOVA).
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Initially, we investigated whether the IRE1α -XBP1 pathway was affected by exposure to NO. We 
found that NO inhibited XBP1 mRNA splicing, but did not affect oligomerization or phosphorylation 
of IRE1α . Additionally, we found that pre-incubation with NO strongly inhibited XBP1 mRNA splicing 
induced by the well-known ER stress agent, thapsigargin. Moreover, our results show that exposure of 
SH-SY5Y neural cells to the PD-inducing agent MPP+, which generates NO, attenuated XBP1 mRNA 
splicing in an NOS inhibitor-dependent manner. From our findings, we concluded that NO inhibited the 
endonuclease activity of IRE1α but not the kinase activity of its cytosolic domain, and that IRE1α did 
not lose its ability to sense the accumulation of unfolded proteins in the ER lumen after exposure to NO.
Next, we determined the Cys residue of IRE1α targeted by NO. Analysis of the atomic structure of 
the cytosolic domain of IRE1α showed that Cys931 and Cys951 are both located in the KEN domain24,25. 
Biotin-switch assay revealed that Cys931 is the predominant site of S-nitrosylation. Importantly, as evi-
dence for a causal relationship of the effect of S-nitrosylation, transduction of IRE1α -null MEFs with 
the C931S mutant increased IRE1α endoribonuclease activity and protected cells from NO-induced cell 
death. These results indicate that the Cys931 residue of IRE1α is critical for redox signaling in the UPR. 
Figure 5. NO-induced phosphorylation of eIF2α. (a) Effect of NO treatment on the phosphorylation 
of PERK and eIF2α . Cells were exposed to varying concentrations of NO for 30 min, and levels of 
phosphorylated PERK, total PERK, phosphorylated eIF2α , total eIF2α , and β -actin were detected  
by immunoblotting. (b) Time-dependent eIF2α phosphorylation after exposure to 100 μ M NO.  
(c) Quantification of eIF2α phosphorylation is shown for (b). Values are mean ± s.e.m. (n = 4; P < 0.05  
or 0.01 by ANOVA).
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Such redox regulation of IRE1α activity has not been previously reported. We then tested whether NO 
can modulate other sensors of ER stress and observed S-nitrosylation of PERK but not ATF6.
Collectively, we found that NO can S-nitrosylate IRE1α and PERK to regulate the UPR. Because the 
IRE1α –XBP1 pathway functions prominently as an anti-apoptotic pathway, this redox-mediated inhibi-
tion by NO hinders cell survival during ER stress. In contrast, prolonged activation of the PERK–eIF2α –
ATF4/ATF6 pathways is known to induce cell death via induction of CHOP. Thus, in conjunction with 
its inhibition of the IRE1α branch of the UPR, NO activation of the PERK-eIF2α pathway would further 
sensitize neural cells to apoptosis. Taken together, we have elucidated the effects of S-nitrosylation on 
ER stress sensors that mediate the UPR, and thus contribute to cell death pathways. These findings have 
important implications for the development new therapeutic approaches for PD and other neurodegen-
erative diseases associated with nitrosative stress and abnormal protein accumulation.
Methods
Materials. Biotin-HPDP was purchased from Pierce Chemical Co. Thapsigargin was obtained from 
Wako Pure Chemical Ltd. All other reagents were obtained from Sigma-Aldrich. Antibodies against 
IRE1α and phospho-IRE1α , PERK, phospho-PERK, ATF6, eIF2α , phospho-eIF2α , and β -actin were 
purchased from Cell Signaling Technology.
Cell culture. Human SH-SY5Y cells and MEFs were maintained in Dulbecco’s modified Eagle’s 
medium supplemented with 10%(v/v) heat-inactivated fetal calf serum at 37 °C in humidified atmos-
phere of 5% CO2/95% air.
Mutagenesis. Mutants of IRE1α were generated by substituting Ser for Cys residues using the 
QuickChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer’s instructions.
Luciferase assay. The XBP1–Luc reporter (ERAI system) and the phRL–TK (Promega, Madison, 
WI) were used in the dual luciferase assay. SH-SY5Y cells were seeded in 24-well plates and were then 
transfected with the plasmids. The cells were lysed after 24 h of transfection, and luciferase assay was 
performed. Reporter activity was measured using Dual-Luciferase 1000 Assay System kit (Promega) and 
a luminometer (Berthold, Bad Wildbad, Germany). The results are expressed as mean ± s.e.m. of three 
experiments. Each value is normalized to fold induction in mock-transfected cells.
RNA extraction and RT-PCR. Total RNA of cells was extracted using TRI reagent (Sigma-Aldrich). 
Transcriptor High Fidelity cDNA Synthesis Kit (Roche, Basel, Switzerland) was used to synthesize the 
cDNA according to the manufacturer’s instructions. The cDNA was amplified by using 24 cycles of PCR. 
The following primers were used: human XBP1 sense primer, 5′ -TTA CGA GAG AAA ACT CAT GGC 
C-3′ ; human XBP1 antisense primer, 5′ -GGG TCC AAG TTG TCC AGA ATG C-3′ ; human EDEM1 
sense primer, 5′ -TCC ATA TCC TCG GGT GAA TC-3′ ; human EDEM1 antisense primer, 5′ -AAA TTC 
CAC CAG GAG GGA AC-3′ ; human GRP78/BiP sense primer, 5′ -GTT TGC TGA GGA AGA CAA 
AAA GCT C-3′ ; human GRP78/BiP antisense primer 5′ -CAC TTC CAT AGA GTT TGC TGA TAA 
TTG-3′ ; human HRD1 sense primer 5′ -GCA CAC CTT CCC ACT CTT TG-3′ ; human HRD1 antisense 
primer 5′ -TGG CAC CAG TCA CCA TCT CT-3′ ; human CHOP sense primer, 5′ -CTC TGG CTT GGC 
TGA CTG A-3′ ; human CHOP antisense primer, 5′ -CTT CAG CTA GCT TGT CCA CT-3′ ; human 
β -actin sense primer, 5′ -CCT GAC GGC CAG GTC ATC-3′ ; human β -actin antisense primer, 5′ -GGA 
CTC GTC ATA CTC CTG-′ ’. PCR products were analyzed by performing agarose gel electrophoresis on 
a 1.5% gel.
Western blotting analysis. SH-SY5Y cells were treated as indicated above, harvested, washed with 
PBS, and lysed in ice-cold lysis buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, and 1% 
NP-40 containing a protease inhibitor cocktail) for 10 min. For detecting of ATF6, the cells were pre-
incubated with or without 50 μ M cycloheximide and 5 μ M MG-132 for 3 h and were further incubated 
during NO treatment. After quantification with Bradford assay, the proteins were boiled in sample load-
ing buffer for 5 min and were electrophoresed by performing SDS-PAGE. The proteins (10 μ g/lane) were 
then transferred onto a PVDF membrane. The membrane was blocked with 5% BSA or non-fat dry 
milk in Tris-buffered saline containing 0.1% Tween-20 for 1 h at room temperature. The membrane was 
then incubated overnight at 4 °C with the antibodies indicated above. The proteins were detected using 
Western Lightning Ultra ECL-HRP substrate (PerkinElmer, Waltham, MA) and visualized using the 
ChemiDoc MP Imaging System (Bio-Rad).
Biotin-switch assay for S-nitrosylated proteins (SNO-P). Cell lysates were prepared in HENT 
buffer (250 mM Hepes, pH7.5, 1 mM EDTA, 0.1 mM neocuproine, 0.1% SDS, and 1% Triton X-100). 
Protein concentration ranges were tested using the biotin-switch assay. Typically, 0.8 mg of cell lysate and 
up to 1.6 mg of tissue extract were used. Samples were mixed with blocking buffer (2.5% SDS and 20 mM 
methylmethanethiosulfonate (MMTS) in HEN buffer) and were incubated at 50 °C for 30 min to block 
free thiol groups. After removing excess MMTS by acetone precipitation, nitrosothiols were then reduced 
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to free thiols by using 1 mM ascorbate. The newly formed thiols were linked to the sulfhydryl-specific 
biotinylating reagent biotin–HPDP. The biotinylated proteins were pilled down using streptavidin–aga-
rose beads, and SNO-P remaining in the samples was detected by performing western blotting.
Assessment of cell viability. Cell viability was measured in triplicate in 24-well plates by perform-
ing a quantitative colorimetric assay with 5-(2, 4-bis[sodiooxysulfonyl]phenyl)-2-(4-nitrophenyl)-3-(4
-iodophenyl)-2H-tetrazole-3- ium (WST-1). Briefly, IRE1α -null MEFs were transfected with 0.4 μ g of 
each gene and were incubated for 24 h. Next, the cells were treated with 100 μ M GSNO for 24 h. Cell 
viability was expressed as the ration of signal obtained from treated cells and signal obtained from con-
trol cells multiplied by 100 (% control).
Statistical analysis. All experiments were independently performed at least three times. All data 
are expressed as the mean ± s.e.m. Statistical comparisons were performed using an ANOVA with a 
Bonferroni correction conducted post hoc using Graphpad Prism 5 (Graphpad Software, La Jolla, CA, 
USA). P values < 0.05 were considered to be significant.
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